Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)

SHE:301130 Revenue

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd had revenue of 45.50M CNY in the quarter ending June 30, 2026, a decrease of -40.20%. This brings the company's total for the last twelve months to 207.96M, down -18.69% year-over-year. In the year 2025, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd had annual revenue of 234.84M, down -8.41%. That makes Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd the 31,093rd largest company in the world by revenue and 5,009th in China.

• Revenue (ttm): 207.96M
• Revenue Growth: -18.69%
• P/S Ratio: 9.44
• Revenue / Employee: 664.40K
• Employees: 313
• Market Cap: 1.96B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceuticals 234.40M 99.8%
• Unallocated Other Business 443.91K 0.2%

Fiscal year ended Dec 31, 2025 See the full SHE:301130 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	234.84M	-21.56M	-8.41%
Dec 31, 2024	256.41M	30.91M	13.71%
Dec 31, 2023	225.49M	-29.98M	-11.73%
Jan 1, 2023	255.47M	-30.19M	-10.57%
Jan 1, 2022	285.66M	-662.79K	-0.23%

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error